1. Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis. (3rd May 2016) Authors: Salvo, Francesco; Moore, Nicholas; Arnaud, Mickael; Robinson, Philip; Raschi, Emanuel; De Ponti, Fabrizio; Bégaud, Bernard; Pariente, Antoine Journal: BMJ Issue: Volume 353(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Advancements in drug development for diarrhea-predominant irritable bowel syndrome. (4th March 2018) Authors: Dothel, Giovanni; Barbaro, Maria Raffaella; Raschi, Emanuel; Barbara, Giovanni; De Ponti, Fabrizio Journal: Expert opinion on investigational drugs Issue: Volume 27:Number 3(2018) Page Start: 251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system. (20th April 2020) Authors: Gatti, Milo; Antonazzo, Ippazio Cosimo; Diemberger, Igor; De Ponti, Fabrizio; Raschi, Emanuel Journal: European journal of preventive cardiology Issue: Volume 28:Number 9(2021) Page Start: 983 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Adverse reactions to dietary supplements containing red yeast rice: assessment of cases from the Italian surveillance system. (19th January 2017) Authors: Mazzanti, Gabriela; Moro, Paola Angela; Raschi, Emanuel; Da Cas, Roberto; Menniti‐Ippolito, Francesca Journal: British journal of clinical pharmacology Issue: Volume 83:Number 4(2017:Apr.) Page Start: 894 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Antipsychotics and Drug-Induced Liver Injury: Toward Minimum Requirements in Reporting Pharmacovigilance Studies. Issue 1 (January 2023) Authors: Raschi, Emanuel; Schoretsanitis, Georgios; Gastaldon, Chiara; Khouri, Charles; Salvo, Francesco; De Ponti, Fabrizio Journal: Journal of clinical psychopharmacology Issue: Volume 43:Issue 1(2023) Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems. Issue 3 (March 2021) Authors: Gatti, Milo; Ippoliti, Ilaria; Poluzzi, Elisabetta; Antonazzo, Ippazio Cosimo; Moro, Paola Angela; Moretti, Ugo; Menniti-Ippolito, Francesca; Mazzanti, Gabriela; De Ponti, Fabrizio; Raschi, Emanuel Journal: Clinical nutrition Issue: Volume 40:Issue 3(2021) Page Start: 1176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Authors' reply to Tufan and colleagues and Boucaud-Maitre. (7th June 2016) Authors: Salvo, Francesco; Moore, Nicholas; Arnaud, Mickael; Robinson, Philip; Raschi, Emanuel; De Ponti, Fabrizio; Bégaud, Bernard; Pariente, Antoine Journal: BMJ Issue: Volume 353(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Baricitinib, JAK inhibitors and liver injury: a cause for concern in COVID-19?. Issue 10 (2nd October 2020) Authors: Raschi, Emanuel; Caraceni, Paolo; Poluzzi, Elisabetta; De Ponti, Fabrizio Journal: Expert opinion on drug safety Issue: Volume 19:Issue 10(2020) Page Start: 1367 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Behavioral excess and disruptive conduct: A historical and taxonomic approach to the origin of the 'impulse control disorders' diagnostic construct. (1st December 2022) Authors: Fusaroli, Michele; Pellegrini, Luca; Fusaroli, Riccardo; Raschi, Emanuel; Menchetti, Marco; Poluzzi, Elisabetta Journal: Addiction Issue: Volume 118:Number 4(2023) Page Start: 763 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Bone fracture as a novel immune‐related adverse event with immune checkpoint inhibitors: Case series and large‐scale pharmacovigilance analysis. Issue 3 (4th May 2021) Authors: Filippini, Daria Maria; Gatti, Milo; Di Martino, Vito; Cavalieri, Stefano; Fusaroli, Michele; Ardizzoni, Andrea; Raschi, Emanuel; Licitra, Lisa Journal: International journal of cancer Issue: Volume 149:Issue 3(2021) Page Start: 675 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗